About Triventures
Triventures: Investing in Exceptional Entrepreneurs for a Better, Healthier Future
Triventures is a global early stage fund that invests in exceptional entrepreneurs who are disrupting the healthcare industry and beyond. The company's vision is to create a better, healthier future through data-driven solutions and cross-industry convergence.
Founded by Dr. Michal Geva and Dr. Eyal Lifschitz in 2010, Triventures has become one of the leading venture capital firms in Israel with offices in Tel Aviv and Boston. The company has invested over $200 million across more than 30 companies, including some of the most innovative startups in healthcare.
Triventures' investment philosophy is centered around identifying disruptive ventures with innovative breakthroughs that have the potential to transform industries. The company focuses on investing in early-stage companies that are developing cutting-edge technologies such as artificial intelligence (AI), machine learning (ML), big data analytics, and digital health solutions.
The team at Triventures comprises experienced professionals from diverse backgrounds such as medicine, engineering, finance, and entrepreneurship. This multidisciplinary approach enables them to identify promising startups with unique value propositions that can revolutionize healthcare delivery systems.
One of Triventure's key strengths lies in its ability to provide strategic guidance to its portfolio companies beyond just financial support. The firm leverages its extensive network of industry experts and mentors to help startups navigate complex regulatory environments while also providing access to key opinion leaders (KOLs) who can offer valuable insights into market trends.
Triventure's portfolio includes several notable companies such as Medisafe - an AI-powered medication management platform; Sweetch - an AI-based diabetes management solution; TytoCare - a telehealth platform for remote medical examinations; DayTwo - personalized nutrition based on gut microbiome analysis; among others.
The success stories of these portfolio companies demonstrate Triventure's ability to identify high-potential startups and provide them with the necessary resources to scale their businesses. The firm's investment in Medisafe, for instance, has helped the company grow its user base to over 7 million patients globally.
Triventures' focus on healthcare innovation is driven by a deep understanding of the challenges facing the industry. The company recognizes that healthcare systems worldwide are under immense pressure due to rising costs, aging populations, and an increasing burden of chronic diseases.
To address these challenges, Triventures invests in companies that are developing solutions that can improve patient outcomes while also reducing costs. By leveraging data-driven technologies such as AI and ML, these startups can help healthcare providers deliver more personalized care while also improving operational efficiency.
In addition to its investments in healthcare startups, Triventures is also exploring opportunities in other industries such as cybersecurity and fintech. The firm believes that cross-industry convergence can lead to new breakthroughs that have the potential to transform multiple sectors simultaneously.
In conclusion, Triventures is a leading early-stage fund focused on investing in exceptional entrepreneurs who are disrupting industries with innovative breakthroughs. With a strong track record of identifying high-potential startups and providing them with strategic guidance beyond just financial support, Triventures is well-positioned to continue driving innovation across multiple sectors for years to come.